AstraZeneca Philippines has inaugurated its new headquarters in Bonifacio Global City in Manila as the Swedish-British healthcare company marks 50 years of operations in the country. The company currently employs around 400 people in Manila.
AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, United Kingdom, with Swedish roots through its 1999 merger with Astra AB. The company focuses on the discovery and development of prescription medicines, particularly in oncology, cardiovascular, renal, metabolism, and respiratory diseases, and operates in over 100 countries.
During the pandemic, AstraZeneca played a significant role in the Philippines’ COVID-19 response with its vaccines. The Swedish embassy, who were in attendance, estimates in a Facebook post that the vaccine roll-out contributed to an estimated 50,000 lives saved. Looking ahead, the company plans to deliver over 7 billion pesos in investments between 2026 and 2028 to strengthen a multi-stakeholder health ecosystem in the country.
The inauguration was attended by Ambassador of Sweden to the Philippines, Anna Ferry, alongside Deputy Head of Mission of the United Kingdom, Mike Welch, Taguig City Mayor Lani Cayetano, and Lotis Ramin, Country President of AstraZeneca Philippines.
